Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR - Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 2,980,000 shares, an increase of 27.4% from the April 30th total of 2,340,000 shares. Based on an average daily volume of 511,500 shares, the short-interest ratio is presently 5.8 days. Currently, 5.4% of the company's stock are short sold.

Wall Street Analyst Weigh In

PHR has been the topic of a number of recent research reports. Truist Financial raised their target price on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Canaccord Genuity Group cut their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research report on Thursday, May 29th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday. DA Davidson dropped their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Finally, Citigroup reiterated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia presently has an average rating of "Buy" and a consensus price target of $31.64.

Phreesia Trading Down 2.1%

Shares of Phreesia stock traded down $0.54 on Wednesday, hitting $25.24. 393,591 shares of the company traded hands, compared to its average volume of 439,424. The stock's 50 day moving average price is $24.73 and its 200-day moving average price is $25.36. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a market cap of $1.50 billion, a PE ratio of -17.17 and a beta of 0.74.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. Phreesia's revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.05) earnings per share. Equities research analysts predict that Phreesia will post -1.1 EPS for the current year.

Insider Buying and Selling at Phreesia

In other news, General Counsel Allison C. Hoffman sold 3,496 shares of the firm's stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares in the company, valued at $3,522,872.88. This trade represents a 2.45% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP David Linetsky sold 4,499 shares of the firm's stock in a transaction on Wednesday, April 16th. The stock was sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the transaction, the senior vice president now owns 217,239 shares in the company, valued at approximately $5,155,081.47. This trade represents a 2.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,474 shares of company stock worth $1,023,208. Insiders own 5.50% of the company's stock.

Hedge Funds Weigh In On Phreesia

Several institutional investors and hedge funds have recently bought and sold shares of the company. Invesco Ltd. grew its holdings in Phreesia by 0.9% in the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after purchasing an additional 357 shares during the last quarter. NewEdge Advisors LLC grew its holdings in shares of Phreesia by 12.1% during the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after buying an additional 459 shares during the last quarter. Arcadia Investment Management Corp MI grew its holdings in shares of Phreesia by 0.7% during the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock valued at $2,371,000 after buying an additional 615 shares during the last quarter. QRG Capital Management Inc. boosted its holdings in Phreesia by 8.0% in the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock valued at $284,000 after purchasing an additional 827 shares during the last quarter. Finally, Johnson Financial Group Inc. boosted its holdings in Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.